Drug intelligence / Profile preview

Azadirachta indica leaf

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical, Ophthalmic
01

Overview

Azadirachta indica leaf, commonly known as Neem, is a botanical extract derived from the leaves of the Neem tree. It contains a complex mixture of bioactive phytochemicals, including limonoids (such as nimbolide and azadirachtin), triterpenoids (nimbin), flavonoids, and alkaloids. The extract is widely studied for its immunomodulatory, anti-inflammatory, and anticancer properties. Mechanistically, Neem leaf preparations (NLP) have been shown to enhance the cytotoxic activity of natural killer (NK) cells and stimulate the release of interleukin-12 (IL-12) from macrophages. These effects are mediated through the activation of the p38 MAPK pathway and the upregulation of CD40 and CD40L. Additionally, the extract modulates several key signaling pathways involved in cell survival and inflammation, including NF-κB, PI3K/Akt, and IGF signaling. While not an approved pharmaceutical drug, it is a staple of traditional Ayurvedic and Unani medicine and is frequently used in over-the-counter products and dietary supplements.

Other names
Neem leafNeem leaf preparationAzadirachta indica leaf extract
02

Targets

CLEC7A (Dectin-1)Mpro (3C-like proteinase of SARS-CoV-2)NS1 (Zika virus nonstructural protein 1)

Beyond the preview

Go deeper on Azadirachta indica leaf.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azadirachta indica leaf.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call